Piperacillin Sodium/Tazobactam Sodium

哌拉西林钠/他唑巴坦钠

Report date: 2026/03/24 20:00:35

Base Information

Drug NamePiperacillin Sodium/Tazobactam Sodium
Drug Alias Name哌拉西林钠他唑巴坦钠piperacillin and tazobactam哌拉西林钠/三唑巴坦钠Piperacillin/tazobactam注射用哌拉西林钠/三唑巴坦钠 +[14] 
ClassificationSmall molecules
Mechanisms of ActionBeta Lactamase inhibitors
TargetsBeta Lactamase
Therapy Area/IndicationsHospital-acquired pneumoniaComplicated Skin and Soft Tissue InfectionsUncomplicated skin and skin structure infections +[16] 
Global Approved IndicationsComplicated Skin and Soft Tissue InfectionsUncomplicated skin and skin structure infectionsPneumonia +[8] 
Approved Indications in ChinaInfections
Original Approved Country/TerritoryFrance
Original Approved Date1992/01/01
Country/TerritoryCanadaUnited StatesSweden +[7] 
CombinationsYes Tazobactam SodiumPiperacillin Sodium
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesWyeth Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAzienda Sanitaria Universitaria Friuli CentraleQilu Tianhe Pharmaceutical Co LtdPfizer Inc +[11] 
Inactive CompaniesWyeth LlcWyeth Pharmaceuticals IncKarolinska Institutet
Active IndicationsHospital-acquired pneumoniaComplicated Skin and Soft Tissue InfectionsUncomplicated skin and skin structure infections +[14] 
Inactive IndicationsCholecystitis, AcuteHematologic Neoplasms

Other Information

ATC CodeJ01CR05
Related LinksWikipediaKEGG